Observational research in rheumatic disorders

Rheumatic Disease Clinics of North America

Volumn 30, Issue 4, 2004, Pages 685-699

  Choi, Hyon K ^a,b   Seeger, John D ^c,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d Ingenix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; STEROID;

ANALYTIC METHOD; CLINICAL OBSERVATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; DIAGNOSTIC TEST; DRUG APPROVAL; DRUG SCREENING; ECONOMIC ASPECT; EXPERIMENT; FOLLOW UP; FOOD INTAKE; HEALTH; HUMAN; HYPOTHESIS; MEDICAL INFORMATION; MEDICAL RESEARCH; MEDICINE; METHODOLOGY; MODEL; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; RHEUMATIC DISEASE; RISK ASSESSMENT; RISK FACTOR; SCIENCE; SCREENING TEST; SOCIAL ASPECT; SYSTEMIC VASCULITIS;

CAUSALITY; EPIDEMIOLOGIC RESEARCH DESIGN; HUMANS; OBSERVATION; RHEUMATIC DISEASES;

EID: 5444241488     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2004.07.004     Document Type: Review

References (51)

1. A.S. Fauci, B.F. Haynes, and P. Katz The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations Ann Intern Med 89 1978 660 676
2. B.L. Isaak, T.J. Liesegang, and C.J. Michet Jr Ocular and systemic findings in relapsing polychondritis Ophthalmology 93 1986 681 689
3. D.D. Gladman, R. Shuckett, M.L. Russell, J.C. Thorne, and R.K. Schachter Psoriatic arthritis (PSA) - an analysis of 220 patients Q J Med 62 1987 127 141
4. Primer on the rheumatic diseases 12th edition 2001 Arthritis Foundation Atlanta (GA)
5. D.T. Felson, Y. Zhang, and M.T. Hannan The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study Arthritis Rheum 38 1995 1500 1505
6. S.A. Oliveria, D.T. Felson, J.I. Reed, P.A. Cirillo, and A.M. Walker Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization Arthritis Rheum 38 1995 1134 1141
7. N. Wiles, D.P. Symmons, and B. Harrison Estimating the incidence of rheumatoid arthritis: trying to hit a moving target? Arthritis Rheum 42 1999 1339 1346
8. R.C. Lawrence, C.G. Helmick, and F.C. Arnett Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States Arthritis Rheum 41 1998 778 799
9. H.K. Choi, K. Atkinson, E.W. Karlson, W.C. Willett, and G. Curhan Purine-rich foods, dairy and protein intake, and the risk of gout in men N Engl J Med 350 2004 1093 1103
10. R. Roubenoff, M.J. Klag, L.A. Mead, K.Y. Liang, A.J. Seidler, and M.C. Hochberg Incidence and risk factors for gout in white men JAMA 266 1991 3004 3007
11. K.M. Uramoto, C.J. Michet Jr, J. Thumboo, J. Sunku, W.M. O'Fallon, and S.E. Gabriel Trends in the incidence and mortality of systemic lupus erythematosus, 1950 - 1992 Arthritis Rheum 42 1999 46 50
12. V.D. Steen, C.V. Oddis, C.G. Conte, J. Janoski, G.Z. Casterline, and T.A. Medsger Jr Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963 - 1982 Arthritis Rheum 40 1997 441 445
13. K.W. Chan, D.T. Felson, R.A. Yood, and A.M. Walker Incidence of rheumatoid arthritis in central Massachusetts Arthritis Rheum 36 1993 1691 1696
14. C.E. Dugowson, T.D. Koepsell, L.F. Voigt, L. Bley, J.L. Nelson, and J.R. Daling Rheumatoid arthritis in women. Incidence rates in group health cooperative, Seattle, Washington, 1987 - 1989 Arthritis Rheum 34 1991 1502 1507
15. E. Yelin, and L.A. Wanke An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline Arthritis Rheum 42 1999 1209 1218
16. K. Michaud, J. Messer, H.K. Choi, and F. Wolfe Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients Arthritis Rheum 48 2003 2750 2762
17. F. Wolfe The natural history of rheumatoid arthritis J Rheumatol Suppl 44 1996 13 22
18. G.S. Alarcon, A.W. Friedman, and K.V. Straaton Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture Lupus 8 1999 197 209
19. K.J. Rothman, and S. Greenland Modern epidemiology 2nd edition 1998 Lippincott - Raven Philadelphia
20. A.B. Hill The environment and disease: association or causation? Proc R Soc Med 58 1965 295 300
21. S. Hernandez-Diaz, M.A. Hernan, K. Meyer, M.M. Werler, and A.A. Mitchell Case-crossover and case-time-control designs in birth defects epidemiology Am J Epidemiol 158 2003 385 391
22. M.E. Weinblatt, J.M. Kremer, and A.D. Bankhurst A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 1999 253 259
23. L.M. Moreland, S.B. Cohen, S. Baumgartner, M. Schiff, E.A. Tindall, and D.J. Burge Long-term use of etanercept in patients with DMARD-refractory rheumatoid arthritis Arthritis Rheum 42 1999 S401
24. V. Strand, S. Cohen, and M. Schiff Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate Arch Intern Med 159 1999 2542 2550
25. P.E. Lipsky, D.M. van der Heijde, and E.W. St Clair Infliximab and methotrexate in the treatment of rheumatoid arthritis N Engl J Med 343 2000 1594 1602
26. C. Bombardier, L. Laine, and A. Reicin Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group N Engl J Med 343 2000 1520 1528
27. F.E. Silverstein, G. Faich, and J.L. Goldstein Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study JAMA 284 2000 1247 1255
28. K.E. Lasser, P.D. Allen, S.J. Woolhandler, D.U. Himmelstein, S.M. Wolfe, and D.H. Bor Timing of new black box warnings and withdrawals for prescription medications JAMA 287 2002 2215 2220
29. S.E. Gabriel, C.S. Crowson, and H.M. Kremers Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years Arthritis Rheum 48 2003 54 58
30. N.J. Goodson, N.J. Wiles, M. Lunt, E.M. Barrett, A.J. Silman, and D.P. Symmons Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients Arthritis Rheum 46 2002 2010 2019
31. D. Krause, B. Schleusser, G. Herborn, and R. Rau Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis Arthritis Rheum 43 2000 14 21
32. R. Ramsey-Goldman, J.E. Dunn, and C.F. Huang Frequency of fractures in women with systemic lupus erythematosus: comparison with United States population data Arthritis Rheum 42 1999 882 890
33. K. Wong, D.D. Gladman, J. Husted, J.A. Long, and V.T. Farewell Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death Arthritis Rheum 40 1997 1868 1872
34. F. Wolfe, D.M. Mitchell, and J.T. Sibley The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
35. E.L. Matteson, K.N. Gold, D.A. Bloch, and G.G. Hunder Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort Am J Med 100 1996 193 196
36. E.J. Amante, and H.K. Choi Mortality impact of common rheumatic disorders: a metaanalysis [abstract] Arthritis Rheum 44 2001 2951
37. M.S. Cepeda, R. Boston, J.T. Farrar, and B.L. Strom Comparison of logistic regression versus propensity score when the number of events is low and there are multiple confounders Am J Epidemiol 158 2003 280 287
38. H.K. Choi, M.A. Hernan, J.D. Seeger, J.M. Robins, and F. Wolfe Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study Lancet 359 2002 1173 1177
39. Choi HK, Curhan G. Beer, liquor, wine, and serum uric acid level - The Third National Health and Nutrition Examination Survey. Arthritis Rheum, in press.
40. S.E. Lane, R.A. Watts, G. Bentham, N.J. Innes, and D.G. Scott Are environmental factors important in primary systemic vasculitis? A case-control study Arthritis Rheum 48 2003 814 823
41. M.A. Hernán, B. Brumback, and J.M. Robins Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men Epidemiology 11 2000 561 570
42. M.A. Hernán, B. Brumback, and J.M. Robins Marginal structural models to estimate the joint causal effect of nonrandomized treatments J Am Stat Assoc 96 2001 440 448
43. J.M. Bathon, R.W. Martin, and R.M. Fleischmann A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis N Engl J Med 343 2000 1586 1593
44. M.E. Weinblatt, H. Kaplan, and B.F. Germain Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial Arthritis Rheum 33 1990 330 338
45. F. Wolfe, and M.A. Cathey Analysis of methotrexate treatment effect in a longitudinal observational study: utility of cluster analysis J Rheumatol 18 1991 672 677
46. F. Wolfe, D.M. Mitchell, and J.T. Sibley The mortality of rheumatoid arthritis Arthritis Rheum 37 1994 481 494
47. J.P. Leigh, and J.F. Fries Mortality predictors among 263 patients with rheumatoid arthritis J Rheumatol 18 1991 1307 1312
48. T. Pincus, R.H. Brooks, and L.F. Callahan Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures Ann Intern Med 120 1994 26 34
49. C. Confavreux, S. Suissa, P. Saddier, V. Bourdes, and S. Vukusic Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group N Engl J Med 344 2001 319 326
50. W.A. Schmidt, H.E. Kraft, K. Vorpahl, L. Volker, and E.J. Gromnica-Ihle Color duplex ultrasonography in the diagnosis of temporal arteritis N Engl J Med 337 1997 1336 1342
51. C. Salvarani, M. Silingardi, and A. Ghirarduzzi Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 137 2002 232 238